Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma

SIMPLE SUMMARY: Neuroblastoma is a type of childhood cancer accounting for approximately 15% of childhood cancer deaths. Despite intensive treatment, including immunotherapy, prognosis of high-risk neuroblastoma is poor. Increasing amounts of research show that the fighting capacity of the immune sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Szanto, Celina L., Cornel, Annelisa M., Tamminga, Sara M., Delemarre, Eveline M., de Koning, Coco C. H., van den Beemt, Denise A. M. H., Dunnebach, Ester, Tas, Michelle L., Dierselhuis, Miranda P., Tytgat, Lieve G. A. M., van Noesel, Max M., Kraal, Kathelijne C. J. M., Boelens, Jaap-Jan, Huitema, Alwin D. R., Nierkens, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123570/
https://www.ncbi.nlm.nih.gov/pubmed/33926057
http://dx.doi.org/10.3390/cancers13092096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123570/
https://www.ncbi.nlm.nih.gov/pubmed/33926057
http://dx.doi.org/10.3390/cancers13092096

Ejemplares similares